Pune, India -- (SBWIRE) -- 01/22/2020 -- Global Digital Neuritis Drug Market By Types (Dorsal Digital Nerves, Palmar Digital Nerves and Plantar Digital Nerves), Mechanism of Action (Anti-inflammatory, , Corticosteroids and Others), Off-Label Drugs (Interferon Beta-1a, Triamcinolone Acetonide, Naproxen Analgesics and Others), Route of Administration (Oral, Intravenous and Others), Treatment (Medication, Ice-Massage and Surgery), Distribution Channel (Direct, Online Pharmacy, Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2027

Get Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-neuritis-drug-market

Market Analysis:

Global Digital Neuritis Drug Market is growing at a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to the lifestyle changes among the people across the world growing healthcare expenditure.

The key market players in the global digital neuritis drug market are Pfizer Inc, Anesiva, Inc, Centrexion Therapeutics, , NEWCHEM, Biofer SPA, Xinhua Pharm, Shanghai General Pharmaceutical Co., Ltd, Zizhu Pharmaceutical Co.,Ltd, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Biogen, ALLERGAN, Merck KGaA, Sanofi, F. Hoffmann-La Roche Ltd, SANTHERA PHARMACEUTICALS, Gensight Biologics, Stealth BioTherapeutics Inc among others.

Market Definition:

Digital neuritis is an inflammation disorder of the nerve tissues which is characterized by pain and tingling in the hand and fingers. It is more prevalent in geriatric population but majorly found in the younger workers with unhealthy lifestyle. People with digital neuritis experienced abnormal burning sensation, weakness as well as loss of coordination in the fingers.

Market Drivers:

- Increasing prevalence of digital neuritis across the world will drive the market growth

- Number of clinical trials is continuously increasing for the development of therapeutics for the treatment of digital neuritis; this factor will also boost the market growth

- Increasing R&D initiatives and expenditure is another factor uplifting the market growth

Market Restraints:

- Lack of awareness amongst people about digital neuritis is hampering the market

- Associated side effects of the drugs are expected to impede the market growth

- Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceutical companies will also hamper the market growth

Segmentation:

By Types

- Dorsal Digital Nerves
- Palmar Digital Nerves
- Plantar Digital Nerves

By Mechanism of Action

- Anti-inflammatory
- Analgesics
- Corticosteroids
- Others

By Off-Label Drugs

- Interferon beta-1a
- Triamcinolone Acetonide
- Naproxen Analgesics
- Others

By Treatment

- Medications
- Ice Massage

By Route of Administration

- Oral
- Intravenous
- Others

By Distribution Channel

- Direct
- Online Pharmacy
- Retailers
- Others

By End-Users

- Hospitals
- Homecare
- Specialty Clinics

By Geography

- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa

Key Development in the Market

- In July 2019, Centrexion Therapeutics is developing CNTX-0290, a SSTR4 agonist for the treatment of chronic pain associated with inflammatory, neuropathic and mixed pain conditions. If the is trial successful, it will change the treatment paradigms across inflammatory disorders and improving millions of patients suffering from pain associated with digital neuritis.

Competitive Analysis:

Global digital neuritis drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of digital neuritis drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

- Current and future of global digital neuritis drug market outlook in the developed and emerging markets.

- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

- Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
- The latest developments, market shares, and strategies that are employed by the major market players.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-digital-neuritis-drug-market

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com